Oxford Nanoimaging (ONI), a leader in super-resolution microscopy, is revolutionizing lipid nanoparticle (LNP) analysis with ...
EVM14 is the first messenger RNA (mRNA) therapeutic vaccine developed internally by the company to gain this approval. Its ...
Founded in 2020, RIBOPRO develops and manufactures high-quality mRNA and LNPs while offering innovative solutions, including sequence optimization algorithms and a proprietary LNP platform.
analysis with the launch of the ONI Application Kitâ„¢: LNP Profiler, the first and only verified solution within the SMLM and super-resolution space for particle analysis. The kit includes a ...
"By providing an automated, super-resolution, and single-particle-based solution, we enable drug discovery researchers to gain deeper insights into their LNP formulations, reduce variability ...